Research Article
MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma
Table 2
Relationship between MYC levels and clinicopathological features of HCC patients.
| | Clinicopathological features | | MYC expression | | Mean ± standard deviation | |
| | Sex | | | >0.05 | | Male | 40 | | | | Female | 19 | | | | Age (years) | | | >0.05 | | ≤45 | 35 | | | | >45 | 24 | | | | Tumor diameter (cm) | | | < 0.05 | | ≤ 4 | 27 | | | | > 4 | 32 | | | | Tissue differentiation | | | < 0.05 | | Poor | 11 | | | | Moderate | 23 | | | | Well | 25 | | | | Lymph node metastasis | | | >0.05 | | Yes | 13 | | | | No | 46 | | | | TNM staging | | | < 0.05 | | I | 19 | | | | II | 25 | | | | IIIa | 15 | | |
|
|
Note: HCC: hepatocellular cancer; TNM: tumor, node, metastases.
|